New study investigates why BIPOC patients may not get antidepressants as prescribed
NCT ID NCT06799078
First seen May 09, 2026 · Last updated May 22, 2026 · Updated 3 times
Summary
This study looks at whether Black, Indigenous, and People of Color (BIPOC) face more barriers to starting or sticking with antidepressants after a one-time psychiatric consultation. Researchers will survey 60 adults diagnosed with depression to see if race affects medication recommendations, dosage, and adherence. The goal is to find ways to make depression treatment more fair for everyone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEPRESSION DISORDERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Centre for Addiction and Mental Health
Toronto, Ontario, M5S 2S1, Canada
Conditions
Explore the condition pages connected to this study.